Development of a rapid identification method for Klebsiella pneumoniae phylogenetic groups and analysis of 420 clinical isolates

Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
Sylvain BrisseJ Verhoef

Abstract

A rapid method combining gyrA PCR-restriction fragment length polymorphism analysis, parC PCR and adonitol fermentation was developed to identify Klebsiella pneumoniae phylogenetic groups KpI, KpII and KpIII. Analysis of 420 clinical isolates from 26 hospitals showed that the three groups were widespread geographically. KpI comprised 80.3% of 305 isolates from blood and 82.2-97.2% of isolates from other clinical sources. KpIII was never found among isolates from urinary tract infections. KpI isolates from blood were generally less susceptible than KpIII isolates to the ten antimicrobial agents tested, with KpII being intermediate. The frequencies of ceftazidime resistance were 21.6% and 8.6% in KpI and KpIII isolates, respectively (p 0.01).

References

Sep 1, 1979·Reviews of Infectious Diseases·J Z Montgomerie
Jan 1, 1991·Zentralblatt Für Bakteriologie : International Journal of Medical Microbiology·D MonnetJ Fleurette
May 1, 1971·Annals of Internal Medicine·R SeldenT C Eickhoff
Mar 8, 2000·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·S BrisseF J Schmitz
Jun 6, 2002·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·J SirotY Rezvani
Apr 1, 2004·Systematic and Applied Microbiology·Mónica RosenbluethEsperanza Martínez-Romero

❮ Previous
Next ❯

Citations

Aug 25, 2006·Journal of Clinical Microbiology·Maria Silvana AlvesBeatriz Meurer Moreira
Aug 6, 2005·Journal of Clinical Microbiology·Laure DiancourtSylvain Brisse
Oct 9, 2013·BMC Infectious Diseases·Stephen E MshanaCan Imirzalioglu
Feb 26, 2011·Current Microbiology·Maíra Espíndola Silva de MeloAna Catarina de Souza Lopes
Oct 4, 2013·Journal of Clinical Microbiology·Sylvain BrisseDominique Decré
Feb 20, 2016·Emerging Infectious Diseases·Sebastien BreurecSylvain Brisse
Jun 24, 2015·Proceedings of the National Academy of Sciences of the United States of America·Kathryn E HoltNicholas R Thomson
Jun 20, 2014·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·E LiapisUNKNOWN ONERBA
Jan 3, 2013·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Abouddihaj BarguiguaMohammed Timinouni
Feb 15, 2005·Veterinary Microbiology·Sylvain Brisse, Engeline van Duijkeren
Apr 18, 2015·BMC Microbiology·Ulises Garza-RamosJuan Tellez-Sosa
Jan 27, 2015·Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases·Abouddihaj BarguiguaNaima Elmdaghri
Jun 13, 2016·International Journal of Food Microbiology·Hao WuHai Xu
Sep 3, 2014·PloS One·Milka P PodderKapil Tahlan
Oct 19, 2016·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Farah Ben TanfousAssia Ben Hassen
Feb 10, 2017·Environmental Microbiology·Camille BlinSylvain Brisse
May 28, 2014·Revista Da Sociedade Brasileira De Medicina Tropical·Alexsandra Maria Silva LimaAna Catarina Souza Lopes
Dec 9, 2015·The American Journal of Tropical Medicine and Hygiene·Coralith GarcíaYolanda Sáenz
May 19, 2017·The Journal of Antimicrobial Chemotherapy·Yasufumi MatsumuraJohann D D Pitout
Feb 28, 2018·Antimicrobial Agents and Chemotherapy·Ryota GomiYasufumi Matsumura
Feb 7, 2018·Frontiers in Cellular and Infection Microbiology·Rebekah M Martin, Michael A Bachman
Jun 13, 2015·Journal of Clinical Microbiology·Gregory J BerryNatalie Williams-Bouyer
May 17, 2019·Clinical Microbiology Reviews·Thomas A Russo, Candace M Marr
Jan 4, 2019·Journal of Clinical Microbiology·Lauren FontanaWilliam Messer

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.